Impact of High-Pillow Sleeping Posture on Intraocular Pressure in Glaucoma
January 28, 2026
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Solganal
Synonyms :
gold the glucose
Class :
antirheumatics
Brand Name :
Solganal
Synonyms :
gold the glucose
Class :
antirheumatics
Dosage Forms & Strengths
Injectable solutions
50mg/ml
Test dose :
10
mg
Solutions
Intramuscular (IM)
one time only
After one week, administer 25mg, intramuscular and repeat a progressive dose of 0.8 to 1g is attained
Maintenance dose: 50mg intramuscular every 3 to 4 weeks, depending on response to the drug
Dosage Forms & Strengths
Injectable solutions
50mg/ml
For children of 6 to 12 years of age
Test dose:
0.25
mg/kg
Solutions
Intramuscular (IM)
one time only
After one week, administer 0.25mg/kg per dose, intramuscular
Maintenance dose: 0.75- 1mg/kg per dose with a maximum dose of 25mg intramuscular every 3 to 4 weeks (total number of doses should be 20)
Refer to adult dosing
it may diminish the excretion rate when combined with corifollitropin alfa resulting in an enhanced serum level
the rate of excretion of aurothioglucose may be reduced with abacavir
the rate of excretion of aurothioglucose may be reduced with aceclofenac
the efficacy of aurothiglucose may be reduced due to an increase in the rate of excretion when taken with acetazolamide
the rate of excretion of aurothioglucose may be reduced with aclidinium
the rate of excretion of aurothioglucose may be reduced with acyclovir
the rate of excretion of aurothioglucose may be reduced with ampicillin
the rate of excretion of aurothioglucose may be reduced with ancestim
the rate of excretion of aurothioglucose may be reduced with atazanavir
the rate of excretion of aurothioglucose may be reduced with bacitracin
the rate of excretion of aurothioglucose may be reduced with baclofen
the rate of excretion of aurothioglucose may be reduced with baricitinib
the rate of excretion of aurothioglucose may be reduced with bicisate
the efficacy of aurothiglucose may be reduced due to an increase in the rate of excretion when taken with benzthiazide
the rate of excretion of aurothioglucose may be reduced with bupropion
the rate of excretion of carbamazepine may be decreased with aurothiglucose
the rate of excretion of aurothioglucose may be reduced with carmustine
the rate of excretion of aurothioglucose may be reduced with cefepime
the rate of excretion of aurothioglucose may be reduced with cetirizine
the rate of excretion of aurothioglucose may be reduced with dacarbazine
the rate of excretion of aurothioglucose may be reduced with desvenlafaxine
the rate of excretion of warfarin may be decreased with aurothioglucose
the rate of excretion of aurothioglucose may be reduced with zaleplon
aurothioglucose leads to a reduction in the rate of excretion of potassium acetate, which leads to an increased level of serum
aurothioglucose leads to a reduction in the rate of excretion of potassium perchlorate, which leads to an increased level of serum
aurothioglucose may decrease the excretion rate of almasilate, leading to higher serum levels
when both drugs are combined, there may be an increased risk or severity of adverse effects
Actions and spectrum:
The exact mechanism of action of aurothioglucose is unclear. However, some research indicates that the aureus cation and sulfhydryl ligand found in aurothioglucose together inhibit adenylyl cyclase activity in human lymphocyte membranes as well as in the membranes of B and T lymphocyte subsets.
Frequency not defined
Bloody diarrhea
Pain in the abdomen
Confusion
Indigestion
Weakness
Nausea
Shortness of breath
Ulcers in mouth
Change of taste
Fainting
Black Box Warning
Not listed
Contraindication/Caution:
Contraindication:
Nose bleed
Hives
Rashes
Bloody diarrhea
Pregnancy consideration:
USFDA pregnancy category: C
Lactation:
Aurothioglucose is known to be excreted in human milk, and hence, it is to be used with caution in lactating mothers.
Pregnancy category:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus `in either the first or second trimester.
Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Pharmacodynamics:
Pharmacokinetics:
Absorption
Absorption of aurothioglucose is slow
Distribution
95-99% of aurothiglucose is bound to albumin
Metabolism
Elimination and excretion
It is primarily excreted through urine.
Half-life:
Administration:
Administer the drug as an intramuscular injection.
Patient information leaflet
Generic Name: aurothioglucose
Why do we use aurothiglucose?
When other anti-inflammatory medications and conservative treatments, such as glucocorticoids, salicylates, etc., are insufficient to control early active adult and juvenile-type rheumatoid arthritis, aurothioglucose is recommended as an adjuvant treatment.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
